SCHEMBL7544926

SCHEMBL7544926

N#Cc1cc(-c2ccc(Cl)cc2)nc(C=S)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 7/20 0.51
MAPT P10636 6/20 0.51
ALDH1A1 P00352 5/20 0.51
LMNA P02545 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
TDP1 Q9NUW8 3/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
ADRB2 P07550 1/20 0.50
KDM4E B2RXH2 8/20 0.48
ADORA2A P29274 1/20 0.42
ADORA1 P30542 1/20 0.42
SQOR Q9Y6N5 1/20 0.40
GAA P10253 3/20 0.39
KMT2A Q03164 5/20 0.38
MEN1 O00255 4/20 0.38
POLB P06746 3/20 0.38
GLA P06280 2/20 0.38
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
CASP1 P29466 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7540516 0.79 KDM4E (0.40) MAPTALDH1A1SMN1; SMN2KDM4EGAA
SCHEMBL603951 0.76 MAPT (0.58) HPGDMAPTALDH1A1LMNASMN1; SMN2
SCHEMBL7544930 0.73 MAPT (0.51) HPGDMAPTALDH1A1LMNASMN1; SMN2
SCHEMBL27919545 0.71 SMN1; SMN2 (0.62) HPGDMAPTALDH1A1LMNASMN1; SMN2
SCHEMBL3564375 0.70 ALDH1A1 (0.48) HPGDMAPTALDH1A1LMNASMN1; SMN2
SCHEMBL27901818 0.67 CTSS (0.51) HPGDMAPTALDH1A1LMNASMN1; SMN2
SCHEMBL26659404 0.67 SCN9A (0.53) HPGDMAPTALDH1A1LMNASMN1; SMN2
SCHEMBL18015624 0.67 ALDH1A1 (0.45) HPGDMAPTALDH1A1LMNASMN1; SMN2
SCHEMBL16939633 0.66 ALDH1A1 (0.50) HPGDMAPTALDH1A1LMNASMN1; SMN2
SCHEMBL22064956 0.66 KDM4E (0.67) HPGDMAPTALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440984-B1 PROTECTION FOR GROWING AND HARVESTED CROPS; CONTROLLING TOBACCO BUDWORMS AND SOUTHERN ARMYWORMS; PESTICIDES; INSECTICIDES; MITICIDES; ANTHELMINTICS BASF AKTIENGESELLSCHAFT (DE) 2002-08-27 US disclosed
US-20020045634-A1 Use of aryl-substituted pyrimidines as insecticidal and acaricidal agents AMERICAN CYANAMID COMPANY 2002-04-18 US disclosed
US-6306866-B1 2-ALKOXY SUBSTITUTED PYRIMIDINE DERIVATIVES AMERICAN CYANAMID COMPANY 2001-10-23 US disclosed
US-6153619-A Aryl-substituted pyrimidines as insecticidal and acaricidal agents AMERICAN CYANAMID COMPANY (US) 2000-11-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020045634-A1 Use of aryl-substituted pyrimidines as insecticidal and acaricidal agents YBX1, YBX3, CYP1B1 HPGD 3524/4885MAPT 3868/4885ALDH1A1 161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.